M&T Bank’s PRA Health Sciences, Inc. PRAH Stock Holding History

M&T Bank’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,075	Closed	-$342K	–	1662
2021 Q2	$342K	Buy	2,075 +9	+0.4%	+$1.5K	﹤0.01%	1208
2021 Q1	$317K	Buy	2,066 +103	+5%	+$14K	﹤0.01%	1216
2020 Q4	$246K	Sell	1,963 -30	-2%	-$3.35K	﹤0.01%	1414
2020 Q3	$202K	Buy	+1,993	New	+$203K	﹤0.01%	1419
2020 Q1	–	Sell	-2,050	Closed	-$228K	–	1728
2019 Q4	$228K	Hold	2,050	–	–	﹤0.01%	1213
2019 Q3	$203K	Sell	2,050 -10	-0.5%	-$993	﹤0.01%	1427
2019 Q2	$204K	Buy	+2,060	New	+$197K	﹤0.01%	1417

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

M&T Bank's PRAH Position: Q3 2021 in Review

M&T Bank sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 2,075 shares — an estimated $342K sold.

M&T Bank first reported a position in PRAH in Q2 2019 and held it in 7 quarters. The position peaked at $342K in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

M&T Bank reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
M&T Bank sold 2,075 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $342K.
M&T Bank first reported a position in PRA Health Sciences, Inc. in Q2 2019 and held it in 7 quarters.
M&T Bank's PRA Health Sciences, Inc. position peaked at $342K in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on M&T Bank's 13F filing for Q3 2021, filed 28 Oct 2021.